The study examines the efficacy of a mindfulness-based neurofeedback protocol designed to improve academic performance and reduce performance anxiety in racial and ethnic minority college students. Using NeuroSky and BrainTrain technology, the intervention incorporates mindfulness principles to enhance participants' self-regulation skills. Continuous heart rate variability (HRV) data is collected to assess stress levels, sleep, and exercise. The research aims to explore the acceptability and feasibility of this approach, with the goal of addressing academic performance and anxiety in this population.
Age range
18 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Total Correct Responses on the Verbal Mental Arithmetic Task - Final Session
Timeframe: Final session at 4 weeks
Academic Anxiety at Final Session
Timeframe: Final session at 4 weeks
Number of Participants Reporting Weekly Experience Themes During the Intervention
Timeframe: From enrollment to the end of treatment at 4 weeks
Academic Anxiety With Beck Anxiety Inventory at Final Session
Timeframe: Final session at 4 weeks
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Timeframe: From enrollment to the end of treatment at 4 weeks